secwatch / observer
8-K filed February 7, 2025, 6:59 PM ET CIK 0001900402
regulatory confidence high sentiment negative materiality 0.80

Evergreen Corp: Nasdaq/NYSE listing notice — Evergreen Corp receives Nasdaq delisting notice for failing to meet minimum 400 shareholders

Evergreen Corp

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Evergreen Corp received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5450(a)(2)
Exact text from the filing
February 3, 2025, Evergreen Corporation (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company did not comply with the minimum 400 total shareholders requirement for contin
View on SEC.gov
Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Evergreen Corp received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5450(a)(2)
Exact text from the filing
February 3, 2025, Evergreen Corporation (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company did not comply with the minimum 400 total shareholders requirement for continued listing on the Nasdaq Global Market, and had failed to regain compliance with Nasdaq Listing Rule 5450(a)(2) during the extension period which ended on January 28, 2025. The Company has until February 10, 2025 to request a hearing before the Nasdaq Hearings Panel (the “Panel”). If the Company does not request a hearing before the Panel by that date, trading in its securitie
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001493152-25-005345
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.